Arf1-Ablation-Induced Neuronal Damage Promotes Neurodegeneration Through an NLRP3 Inflammasome-Meningeal γδ T cell-IFNγ-Reactive Astrocyte Pathway
Guohao WangiD, Weiqin YiniD, Hyun‐Hee ShiniD, Xianyu Steven HouiD
Abstract
Neurodegenerative diseases are often initiated from neuronal injury or disease and propagated through neuroinflammation and immune response. However, the mechanisms by which injured neurons induce neuroinflammation and immune response that feedback to damage neurons are largely unknown. Here, we demonstrate that Arf1 ablation in adult mouse neurons resulted in activation of a reactive microglia-A1 astrocyte-C3 pathway in the hindbrain and midbrain but not in the forebrain, which caused demyelination, axon degeneration, synapse loss, and neurodegeneration. We further find that the Arf1-ablated neurons released peroxided lipids and ATP that activated an NLRP3 inflammasome in microglia to release IL-1{beta}, which together with elevated chemokines recruited and activated {gamma}{delta}T cells in meninges. The activated {gamma}{delta} T cells then secreted IFN{gamma} that entered into parenchyma to activate the microglia-A1 astrocyte-C3 neurotoxic pathway for destroying neurons and oligodendrocytes. Finally, we show that the Arf1-reduction-induced neuroinflammation-IFN{gamma}-gliosis pathway exists in human neurodegenerative diseases, particularly in amyotrophic lateral sclerosis and multiple sclerosis. This study illustrates perhaps the first complete mechanism of neurodegeneration in a mouse model. Our findings introduce a new paradigm in neurodegenerative research and provide new opportunities to treat neurodegenerative disorders.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of IL34 unveils tissue-selectivity and is sufficient to reduce microglial proliferation in chronic neurodegeneration
Juliane Obst, Emilie Simon, … Diego Gómez‐Nicola·Frontiers in ImmunologyPeer-reviewed·Oct 8, 2020
- Targeting neuroinflammation by pharmacologic down-regulation of inflammatory pathways is neuroprotective in protein misfolding disorders.
Sydney J. Risen, Sean W. Boland, … Julie A. Moreno·ACS Chemical NeurosciencePeer-reviewed·Mar 20, 2024
- Genetically perturbed myelin as a risk factor for neuroinflammation-driven axon degeneration
Janos Groh, Tassnim Abdelwahab, … Rudolf Martini·Nature CommunicationsPeer-reviewed·Oct 30, 2023
- IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease.
Radhika Joshi, Veronika Brezáni, … Gyöngyi Szabó·Journal of NeuroinflammationPeer-reviewed·Aug 30, 2024
- Neuroinflammation links the neurogenic and neurodegenerative phenotypes of Nrmt1-/- mice
James P. Catlin, Shane Fraher, … Christine E. Schaner Tooley·bioRxiv·Sep 2, 2025
- Brain-Penetrant NF-κB and NLRP3 Targeting Nanoligomers are Therapeutic in Amyotrophic Lateral Sclerosis (ALS) and Alzheimers Disease (AD) Human Organoid and Mouse Models
Sadhana Sharma, Devin Wahl, … Prashant Nagpal·bioRxiv·Mar 7, 2024